HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector

AIDS Research and Therapy

Volumn 2, Issue 1, 2005, Pages

  Anderson, Joseph ^a   Akkina, Ramesh ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Bispecific lentiviral vector; CCR5 siRNA; CXCR4 siRNA; HIV 1 co receptors; HIV AIDS gene therapy

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GREEN FLUORESCENT PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE SILENCING; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRUS VECTOR; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR DOWN REGULATION; REPORTER GENE; RNA INTERFERENCE; T LYMPHOCYTE; TARGET CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS IMMUNITY; VIRUS RESISTANCE;

EID: 33845221484     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-2-1     Document Type: Article

References (53)

1. Malim MH, Freimuth WW, Liu J, Boyle TJ, Lyerly HK, Cullen BR, Nabel GJ: Stable expression of transdominant rev protein in human T cells inhibits Human Immunodeficiency Virus replication. J Exp Med 1992, 176:1197-1201.
2. Bonyhadi ML, Moss K, Voytovich A, Auten J, Kalfoglou C, Plavec I, Forestell S, Su L, Bohnlein I, Kaneshima H: RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J Virol 1997, 71:4707-4716.
3. Ding SF, Lombardi R, Nazari R, Joshi S: A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and transdominant negative mutant Gag and Env proteins. Front Biosci 2002, 7:a 15-28.
4. Michienzi A, Li S, Zaia JA, Rossi J: A nucleolar TAR decoy inhibitor of HIV-1 replication. Proc Natl Acad Sci 2002, 99:14047-14052.
5. Akkina R, Banerjea A, bai J, Anderson J, Li MJ, Rossi J: siRNAs, ribozymes, and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS. Anticancer Res 2003, 23:1997-2006.
6. Bahner I, Kearns K, Hao QL, Smogorzewska EM, Kohn DB: Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type I replication in myelomonocytic cells produced in long-term culture. J Virol 1996, 70:4352-4360.
7. Lisziewicz J, Sun D, Smythie J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC: Inhibition of human immunodeficiency virus type I replication by regulated expression of a polymeric tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc Natl Acad Sci USA 1993, 90:8000-8004.
8. Bai J, Gorantla S, Banda N, Cagnon L, Rossi J, Akkina R: Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo. Mol Ther 2000, 1:244-254.
9. Bai J, Rossi J, Akkina R: Multivalent anti-CCR5 ribozymes for stem cell-based HIV type I gene therapy. AIDS Res Hum Retroviruses 2001, 17:385-399.
10. Bai J, Banda N, Lee NS, Rossi J, Akkina R: RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model. Mol Ther 2002, 6:770-782.
11. Cagnon L, Rossi J: Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VAI-ribozyme chimeric transcripts. Antisense Nucleic Acid Drug Dev 2000, 10:251-261.
12. Feng Y, Leavitt M, Tritz R, Duarte E, Kang D, Mamounas M, Gilles P, Wong-Staal F, Kennedy S, Merson J, Yu M, Barber JR: Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5. Virology 2000, 276:271-278.
13. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
14. Fire A, xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
15. Hannon GJ: RNA Interference. Nature 2002, 418:244-251.
16. Sharp P: RNA interference-2001. Genes Dev 2001, 15:485-490.
17. Lee NS, Dohjima T, Bauer G, Li H, Li M, Ehsani A, Salvaterra P, Rossi J: Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002, 20:500-505.
18. Song E, Lee S, Dykxhoorn DM, Novina C, Zhang D, Crawford K, Cerny J, Sharp PA, Leiberman J, Manjunath N, Shankar P: Sustained small interfering RNA-mediated human immunodeficiency virus type I inhibition in primary macrophages. J Virol 2003, 77:7174-7181.
19. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee S, Collman RG, Lieberman J, Shankar P, Sharp PA: siRNA-directed inhibition of HIV-1 infection. Nat Med 2002, 8:681-686.
20. Jacque J, Triques K, Stevenson M: Modulation of HIV-1 replication by RNA interference. Nature 2002, 418:435-438.
21. Martinez MA, Gutierrez A, Armand-Ugon M, Blanco J, Parera M, Gomez J, Clotet B, Este JA: Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 2002, 16:2385-2390.
22. Coburn GA, Cullen BR: Potent and specific inhibition of human immunodeficiency virus type-I replication by RNA interference. J Virol 2002, 76:9225-9231.
23. Anderson J, Banerjea A, Planelles V, Akkina R: Potent suppression of HIV type I infection by a short hairpin anti-CXCR4 siRNA. AIDS Res Hum Retroviruses 2003, 19:699-706.
24. Anderson J, Banerjea A, Akkina R: Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance. Oligonucleotides 2003, 13:303-312.
25. Capodici J, Kariko K, Weissman D: Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol 2002, 169:5196-5201.
26. Haasnoot PCJ, Cupac D, Berkhout B: Inhibition of virus replication by RNA interference. J Biomed Sci 2003, 10:607-616.
27. Lee MM, Coburn G, McClure MO, Cullen BR: Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using tat-or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 2003, 77:11964-11972.
28. Li M, Bauer G, Michienzi A, Yee J, Lee NS, Kim J, Li S, Castanotto D, Zaia J, Rossi J: Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther 2003, 8:196-206.
29. Banerjea A, Li M, Bauer G, Remling L, Lee NS, Rossi J, Akkina R: Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in lymphocytes diferentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther 2003, 8:62-71.
30. Butticaz C, Ciuffi A, Munoz M, Thomas J, Bridge A, Pebernard S, Iggo R, Meylan P, Telenti A: Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spetrum of CCR5 expression. Antiviral Therapy 2003, 8:373-377.
31. Qin X, An DS, Chen ISY, Baltimore D: Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2003, 100:183-188.
32. Bieniasz PD, Cullen BR: Chemokine receptors and Human Immunodeficiency Virus infection. Front Biosci 1998, 3:44-58.
33. Berger EA, Murphy PM, Farber JM: Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 1999, 17:657-700.
34. Liu R, Paxton W, Choe S, Ceradini D, Martin S, Horuk R, MacDonald M, Stuhlman H, Koup R, Landau N: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell 1996, 86:367-377.
35. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, Kang S, Ceradini D, Jin Z, Yazdanbakhsh K, Kunstman K, Erickson D, Dragon E, Landau NR, Phair J, Ho DD, Koup RA: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996, 2:1240-1243.
36. Naif HM, Cunningham AL, Alali M, Li S, Nasr N, Buhler MM, Schols D, Clercq E, tewart G: A human immunodeficiency virus type I isolate from an infected person homozygous for CCR5Δ32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4. J Virol 2002, 76:3114-3124.
37. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4-and SDF-I-deficient mice. Proc Natl Acad Sci USA 1998, 95:9448-9453.
38. Yam P, Li S, Wu J, Hu J, Zaia J, Yee J: Design of HIV-1 vectors for efficient gene delivery into human hematopoietic cells. Mol Their 2002, 6:770-782.
39. Ailles LE, Naldini L: HIV-1 Derived Lentiviral Vectors. In Lentiviral Vectors Edited by: Trono D. Berlin: Springer-Verlag; 2002:31-48.
40. Castanotto D, Li H, Rossi J: Functional siRNA expression from transfected PCR products. RNA 2002, 8:1454-1460.
41. Kimpton J, Emerman M: Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J Virol 1992, 66:2232-2239.
42. Vodicka MA, Goh WC, Wu LI, Rogel ME, Bartz SR, Schweickart VL, Raport CJ, Emerman M: Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology 1997, 233:193-198.
43. Morner A, Bjorndal A, KewalRamani V, Littman DR, Inoue R, Thorstensson R, Fenyo EM, Bjorling E: Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 1999, 73:2343-2349.
44. VandenDriessche T, Naldini L, Collen D, Chuah MKL: Oncoretroviral and lentiviral vector-mediated gene therapy. Methods in Enzymol 2002, 346:573-589.
45. Ketteler R, Glaser S, Sandra O, Martens UM, Klingmuller U: Enhanced trnsgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently trnsduced by optimized retroviral hybrid vectors. Gene Therapy 2002, 9:477-487.
46. An DS, Koyanagi Y, Zhao J, Akkina R, Bristol G, Yamamoto N, Zack JA, Chen ISY: High-efficiency transduction of huma lymphoid progenitor cells and expression in differentiated T cells. J Virol 1997, 71:1397-1404.
47. Mautino MR, Morgan RA: Gene therapy of HIV-1 infection using lentiviral vectors expressing anti-HIV-1 genes. AIDS Patient Care and STDs 2002, 16:11-26.
48. Moss EG, Taylor JM: Small-interfering RNAs in the radar of the interferon system. Nat Cell Biol 2003, 5:771-772.
49. Pebernard S, Iggo RD: Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation 2004, 72:103-111.
50. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M, Collins FS: Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci USA 2004, 101:1892-1897.
51. Molyneaux KA, Zinszner H, Kunwar PS, Schaible K, Stebler J, Sunshine MJ, O'Brien W, Raz E, Littman D, Wylie C, Lehmann R: The chemokine SDF1/ CXCL12 and its receptor CXCR4 regulate mouse germ cell migration and survival. Development 2002, 130:4279-4286.
52. Coffield VM, Jiang Q, Su L: A genetic approach to inactivating chemokine receptors using a modified viral protein. Nat Biotechnol 2003, 21:1321-1327.
53. Jackson AL, Bartz SR, Shelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS: Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003, 21:635-637.